#200: Insulin and QWINT-1 Trial in T2DM: Beyond Journal Club Segment with NEJM Group

0:00-28:14

From metformin to basal insulin to overlooked older medications, this episode reviews the T2D medication toolkit clinicians use every day. We then dive into new evidence on once-weekly insulin to help you individualize therapy while reducing treatment burden. 🔹 Sponsor: Pain Management and Opioids Adaptive Learning Free Online Course by NEJM Group: https://cme-info.nejm.org/core-im/ 🔹Transcript and Shownotes: 00.58 | Insulin Hx & Types 06:00 | Indications for Insulin and the Burden on Patients 08:26 | What is the QWINT-1 Trial? 16:18 | Discussion Tags: CoreIM, Internal Medicine, Evidence-Based Medicine, Insulin Resistance, Clinical Reasoning, Hospital Medicine, Medical Education, Endocrine, Endocrinology Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840 Our Sponsors: * Check out Eko: https://ekohealth.com * Check out ElevenReader and use my code PODCAST for a great deal: https://elevenreader.io * Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com

Publisher

Core IM | Internal Medicine Podcast

Link

www.coreimpodcast.com/2026/02/11/insulin-and-qwint-1-trial/

Published

February 11, 2026

Duration

28 min

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

Host

Core IM Team

CI

Core IM | Internal Medicine Podcast

@coreiminternalmedicinepodcas

#insulin #journalclubsegment #nejmgroup #medicine #mentalhealth

The Nile